BACE inhibitor treatment starting at 34 days of cBOs differentiation until 100-day-old cBOs, resulted in a significant reduction in 4HNE levels (Fig. 6d) and increased ferritin expression in AD compared to isogenic brain organoids (Fig. 6e). This evidence concerns the gene BACE1 and Alzheimer disease.